These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8571733)

  • 1. Tumor necrosis factor and lymphotoxin ligand-receptor system in lymphoproliferative disorders.
    Warzocha K; Salles G; Coiffier B
    Acta Haematol Pol; 1995; 26(4):323-32. PubMed ID: 8571733
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphotoxin and tumor necrosis factor: qualitative and quantitative differences in their receptors and signal transduction in various cell types.
    Aggarwal BB
    Prog Clin Biol Res; 1990; 349():375-84. PubMed ID: 2169060
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokines and cytokine receptors.
    Trinchieri G
    Immunol Rev; 2004 Dec; 202():5-7. PubMed ID: 15546382
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands.
    Pfeffer K
    Eur Cytokine Netw; 2000 Sep; 11(3):514. PubMed ID: 11203200
    [No Abstract]   [Full Text] [Related]  

  • 5. The tumor necrosis factor ligand and receptor families.
    Bazzoni F; Beutler B
    N Engl J Med; 1996 Jun; 334(26):1717-25. PubMed ID: 8637518
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor necrosis factor and lymphotoxin: molecular genetics, regulation and physiological role].
    Nedospasov SA
    Genetika; 2003 Feb; 39(2):207-14. PubMed ID: 12669416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotoxin and LIGHT signaling pathways and target genes.
    Schneider K; Potter KG; Ware CF
    Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting.
    Matsumoto M
    J Med Invest; 1999 Aug; 46(3-4):141-50. PubMed ID: 10687308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.
    Spahn TW; Eugster HP; Fontana A; Domschke W; Kucharzik T
    Infect Immun; 2005 Nov; 73(11):7077-88. PubMed ID: 16239501
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of TNF and lymphotoxin on the hematopoietic system.
    Trinchieri G
    Immunol Ser; 1992; 56():289-313. PubMed ID: 1550864
    [No Abstract]   [Full Text] [Related]  

  • 11. The TNF-TNF receptor system.
    Hehlgans T; Männel DN
    Biol Chem; 2002 Oct; 383(10):1581-5. PubMed ID: 12452434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ligands and receptors of the lymphotoxin system.
    Ware CF; VanArsdale TL; Crowe PD; Browning JL
    Curr Top Microbiol Immunol; 1995; 198():175-218. PubMed ID: 7774281
    [No Abstract]   [Full Text] [Related]  

  • 13. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.
    Kuprash DV; Alimzhanov MB; Tumanov AV; Anderson AO; Pfeffer K; Nedospasov SA
    J Immunol; 1999 Dec; 163(12):6575-80. PubMed ID: 10586051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M; Medvedev AE; Sundan A; Espevik T
    Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin and the release of tumor necrosis factor receptors.
    Jansen J; van der Poll T; van Deventer SJ
    Prog Clin Biol Res; 1994; 388():383-97. PubMed ID: 7831370
    [No Abstract]   [Full Text] [Related]  

  • 16. Turning off follicular dendritic cells.
    Mackay F; Browning JL
    Nature; 1998 Sep; 395(6697):26-7. PubMed ID: 9738494
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
    Sacca R; Cuff CA; Lesslauer W; Ruddle NH
    J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
    Raine CS; Bonetti B; Cannella B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin.
    Hayder H; Blanden RV; Körner H; Riminton DS; Sedgwick JD; Müllbacher A
    J Immunol; 1999 Aug; 163(3):1516-20. PubMed ID: 10415054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines.
    Phillips TA; Ni J; Hunt JS
    Placenta; 2001; 22(8-9):663-72. PubMed ID: 11597186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.